OBJECTIVES The purpose of this study was to assess usage patterns of transradial access in rescue percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) and associations between vascular access site choice and outcomes.
F ibrinolytic therapy is a cornerstone of therapy in patients with ST-segment elevation myocardial infarction (STEMI) who present to facilities that do not offer prompt access to primary percutaneous coronary intervention (PCI). At least 12% to 17% of patients in the United States are treated with fibrinolytic therapy (1, 2) . Up to 40% to 50% of patients do not achieve restoration of Thrombolysis
In Myocardial Infarction flow grade 3 in the infarctrelated artery after administration of full-dose fibrinolytic therapy (3, 4) and may undergo urgent cardiac catheterization with coronary intervention, so-called "rescue PCI." In the setting of antithrombotic and antiplatelet agents used to treat acute coronary syndromes, bleeding complications in patients with STEMI are common and are associated with worse clinical outcomes and prognosis (5) . These risks may be increased in those receiving fibrinolytic therapy for STEMI prior to cardiac catheterization (6) .
Many of these bleeding complications are related to the femoral artery access site used for cardiac catheterization (7) .
Several analyses have demonstrated a reduction in bleeding outcomes in STEMI patients undergoing PCI via the transradial approach (8) (9) (10) (11) (12) (13) (14) . However, little is known about differences in bleeding outcomes on the basis of access approach in patients undergoing rescue PCI. Given their high-risk clinical presentation and the concurrent use of antiplatelet, anticoagulant, and thrombolytic therapy, these patients may have the most to gain from "bleeding-avoidance strategies" like radial access. However, patients who fail to reperfuse with thrombolysis represent a high-risk subgroup whose procedural success rates may be worse, and the influence of transradial access upon procedural success and mortality in this group is unknown.
The National Cardiovascular Data Registry (NCDR)
CathPCI Registry provides a unique opportunity to evaluate access site usage patterns and the differences in bleeding outcomes and mortality in patients undergoing transradial versus transfemoral access following fibrinolytic therapy in STEMI in clinical practice. We hypothesized that transradial access would be associated with improved outcomes in rescue PCI patients. 
TR Versus TF Access for Rescue PCI (percentages), and differences were assessed using the chi-square test. Continuous variables are presented as medians with interquartile ranges and were compared using the Wilcoxon rank-sum test.
We accounted for potential selection bias in those who underwent transradial versus transfemoral procedures by constructing a propensity model for vascular access using logistic regression. Variables were selected a priori in a nonparsimonious fashion from the NCDR CathPCI version 4 pre-catheterization in-hospital mortality and bleeding models (8, 18) . 
RESULTS
BASELINE CHARACTERISTICS AND TREATMENT.
Among 9,494 patients undergoing rescue PCI Kadakia et al.
following fibrinolytic therapy for STEMI, 8,146 (85.8%)
had femoral access and 1,348 (14.2%) had radial access. Those undergoing radial access were more often younger and male, and more often had higher BMI, family history of coronary artery disease, and history of congestive heart failure. They less often had a history of hypertension, dyslipidemia, previous coronary artery bypass graft surgery, cerebrovascular disease, or chronic lung disease ( Table 1) .
On presentation, patients undergoing radial access less often had heart failure within the 2 weeks prior to presentation, cardiogenic shock, and cardiac arrest.
Mean glomerular filtration rate was higher in the radial access group. There was no statistically significant difference in baseline hemoglobin levels. The median time from fibrinolytic administration to cardiac catheterization was 189 min (interquartile range:
108 to 918 min). There were no differences in ejection fraction between the 2 groups. Radial access patients more often received aspirin and unfractionated
heparin. There were no other statistically significant differences in medical therapies between the 2 groups, including usage of thienopyridines and GP IIb/IIIa inhibitors ( Table 2) . Table 3) . GFR ¼ glomerular filtration rate; HF ¼ heart failure; NYHA ¼ New York Heart Association;
PCI ¼ percutaneous coronary intervention.
DISCUSSION
We found that the majority of patients in the United However, these studies were unadjusted analyses that were modest in size.
To our knowledge, there has been no large trial or observational analysis with statistical adjustment that has analyzed the association of access approach with bleeding complications and mortality specifically in STEMI patients treated with fibrinolytic therapy who have undergone rescue PCI. The current analysis also represents by far the largest population Values are mean AE SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft surgery; CAD ¼ coronary artery disease; CHF ¼ congestive heart failure; GFR ¼ glomerular filtration rate (using the Modification of Diet in Renal Disease study equation); MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention. Kadakia et al. Another possibility is that the post-thrombolytic milieu may create a more favorable environment that leads to less distal embolization and no-reflow phenomenon, improving mortality to such a degree that it eliminates the propensity-matched mortality benefit in the radial group. Alternatively, given the low in-hospital mortality rates seen in the present analysis, it is possible that we did not have the power to accurately assess mortality in this patient group.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S
Our findings raise several interesting questions for future research and development in the understudied rescue PCI population. Other bleeding avoidance strategies, such as the use of bivalirudin, have been shown to reduce bleeding in STEMI, but have not been studied specifically in the rescue PCI population (31) . Importantly, in our analysis, even in In addition to possible residual confounding, our study has limitations inherent to registry analysis.
The examined registry only contained data regarding in-hospital mortality. It is possible that radial access could confer a mortality benefit over the longer term (30 days or 2 years), as has been suggested by prior studies of radial access in STEMI (11, 13, 14 
CONCLUSIONS
In a large, "real-world" registry, transradial access was used in 15% of patients undergoing rescue PCI with high procedural success rates. Propensitymatched analyses suggested significantly less bleeding associated with a transradial approach in this population. Given persistent differences in a falsification endpoint, the influence of treatmentselection bias on these results cannot be ruled out.
However, given the lack of research regarding bleeding avoidance in rescue PCI, the present study is likely to represent the best available data in this area for the foreseeable future.
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